SCHEMBL684086

SCHEMBL684086

CCN1CCN(N(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
CHRNA7 P36544 1/20 0.37
TSHR P16473 1/20 0.36
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
RAD52 P43351 1/20 0.34
GFER P55789 1/20 0.34
HPGD P15428 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN5 P54829 1/20 0.34
PTPN11 Q06124 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
KMT2A Q03164 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL3419162 0.97 ALDH1A1 (0.39) ALDH1A1CHRNA7TSHRMAPTSMN1; SMN2
SCHEMBL27638822 0.91 ALDH1A1 (0.35) ALDH1A1CHRNA7TSHRMAPTSMN1; SMN2
Trimethylammonium SCHEMBL31097229 0.82
SCHEMBL22520619 0.82 ACHE (0.40) ALDH1A1SMN1; SMN2KDM4ESIGMAR1
SCHEMBL2925203 0.79 DRD2 (0.41) KDM4EGAASIGMAR1
SCHEMBL22307131 0.79 TSHR (0.39) TSHRSMN1; SMN2KDM4EGAA
SCHEMBL84808 0.78 CHRNA7 (0.48) ALDH1A1CHRNA7MAPTSMN1; SMN2KDM4E
SCHEMBL577415 0.78 CHRNA7 (0.48) ALDH1A1CHRNA7MAPTSMN1; SMN2KDM4E
SCHEMBL6657817 0.78 CHRNA7 (0.48) ALDH1A1CHRNA7MAPTSMN1; SMN2KDM4E
SCHEMBL577052 0.78 CHRNA7 (0.48) ALDH1A1CHRNA7MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380572-B1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL ONYCHOPHARM GMBH (DE) 2025-10-01 EP disclosed
EP-4380572-A1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL OnychoPharm GmbH (DE) 2024-06-12 EP disclosed
WO-2023011750-A1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL ONYCHOPHARM GMBH (DE) 2023-02-09 WO disclosed
EP-4129292-A1 FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL OnychoPharm GmbH (DE) 2023-02-08 EP disclosed
EP-3448386-B1 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF SAMUMED LLC (US) 2021-03-03 EP disclosed
EP-2831067-B1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF UNIV MICHIGAN REGENTS (US) 2017-11-01 EP disclosed
US-9393218-B2 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers EPINAMICS GMBH (DE) 2016-07-19 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed
EP-1962815-B1 USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS EPINAMICS GMBH (DE) 2010-08-11 EP disclosed
EP-1962815-A1 USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS Epinamics GmbH (DE) 2008-09-03 EP disclosed
US-20080051399-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS ARRAY BIOPHARMA INC. 2008-02-28 US disclosed
US-20070248658-A1 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers EPINAMICS GMBH (DE) 2007-10-25 US disclosed
WO-2007077029-A1 USE OF FILM-FORMING HAIR-CARE POLYMERS FROM THE GROUP OF POLYURETHANES AND PHARMACEUTICAL PREPARATIONS AND PLASTERS CONTAINING SAID POLYMERS EPINAMICS GMBH (DE) 2007-07-12 WO disclosed
EP-1800671-A1 Use of film-forming hair care polymers and pharmaceutical preparations and patches comprising such polymers Bayer Schering Pharma Aktiengesellschaft (DE) 2007-06-27 EP disclosed
US-7141647-B2 Image file arrangement for use with an improved image quality assurance system KABUSHIKI KAISHA TOSHIBA (JP) 2006-11-28 US disclosed
US-20050020701-A1 Method of treating waste product containing flexible polyurethane resin KABUSHIKI KAISHA TOSHIBA (JP) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051399-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS AKT1, AKT2, AKT1S1 ALDH1A1 1715/4885CHRNA7 4875/4885TSHR 4108/4885
US-20070248658-A1 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers CUTA, PUF60, TET3 ALDH1A1 1133/4885CHRNA7 3071/4885TSHR 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.